INSPHERO

In News

InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities - Business Wire

Business Wire - May 20, 2026

Label-free quantification of tumor spheroid drug responses in InSphero ARCTis™ Plates - SelectScience

SelectScience - Aug 05, 2026

InSphero acquires PhenoVista to expand US presence - Startupticker.ch

Startupticker.ch - May 26, 2026

Physicians Committee and InSphero Announce Winners of HUMAIN Award - Physicians Committee for Responsible Medicine

Physicians Committee for Responsible Medicine - Oct 21, 2025

InSphero 3D InSight Microtissues enable scalable, assay-ready drug discovery workflows - SelectScience

SelectScience - Jun 25, 2026

InSphero acquires DOPPL SA and Sun Bioscience Gri3D Technology - Startupticker.ch

Startupticker.ch - Nov 12, 2025

Prediction of Liver Toxicity Revolutionized in Largest 3D In Vitro Benchmarking Study - Technology Networks

Technology Networks - Jan 03, 2025

Building better drugs: how 3D models are shaping pre-clinical development - Drug Target Review

Drug Target Review - Apr 25, 2025

Getting the Hang of 3D Liver Microtissues - Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology News - Jun 29, 2016

Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model - Nature

Nature - Mar 11, 2024

Detecting hepatotoxic drugs with human liver microtissues - News-Medical

News-Medical - Nov 18, 2024

Biotech Firm Invents Always-Upright Shipping Container - Packaging Digest

Packaging Digest - Dec 14, 2020

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment